Literature DB >> 9875028

Position paper on the use of botulinum toxin in cerebral palsy. UK Botulinum Toxin and Cerebral Palsy Working Party.

L J Carr1, A P Cosgrove, P Gringras, B G Neville.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9875028      PMCID： PMC1717702          DOI： 10.1136/adc.79.3.271

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  17 in total

1.  Concurrent and construct validity of the Pediatric Evaluation of Disability Inventory.

Authors:  A B Feldman; S M Haley; J Coryell
Journal:  Phys Ther       Date:  1990-10

Review 2.  Therapeutic uses of botulinum toxin.

Authors:  J Jankovic; M F Brin
Journal:  N Engl J Med       Date:  1991-04-25       Impact factor: 91.245

3.  Botulinum toxin treatment in cerebral palsy: intervention with poor evaluation?

Authors:  H Forssberg; K B Tedroff
Journal:  Dev Med Child Neurol       Date:  1997-09       Impact factor: 5.449

4.  The origin, structure, and pharmacological activity of botulinum toxin.

Authors:  L L Simpson
Journal:  Pharmacol Rev       Date:  1981-09       Impact factor: 25.468

5.  Development of resistance to botulinum toxin type A in patients with torticollis.

Authors:  P Greene; S Fahn; B Diamond
Journal:  Mov Disord       Date:  1994-03       Impact factor: 10.338

6.  Long-term botulinum toxin treatment of focal hand dystonia.

Authors:  B I Karp; R A Cole; L G Cohen; S Grill; J S Lou; M Hallett
Journal:  Neurology       Date:  1994-01       Impact factor: 9.910

7.  Botulinum A chemodenervation: a new modality in cerebral palsied hands.

Authors:  S A Wall; L A Chait; J A Temlett; B Perkins; G Hillen; P Becker
Journal:  Br J Plast Surg       Date:  1993-12

8.  Botulinum toxin in the management of the lower limb in cerebral palsy.

Authors:  A P Cosgrove; I S Corry; H K Graham
Journal:  Dev Med Child Neurol       Date:  1994-05       Impact factor: 5.449

9.  Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia.

Authors:  J Jankovic; K S Schwartz
Journal:  Neurology       Date:  1993-04       Impact factor: 9.910

10.  Management of cerebral palsy with botulinum-A toxin: preliminary investigation.

Authors:  L A Koman; J F Mooney; B Smith; A Goodman; T Mulvaney
Journal:  J Pediatr Orthop       Date:  1993 Jul-Aug       Impact factor: 2.324
View more
  9 in total

Review 1.  Botulinum toxin for cerebral palsy; where are we now?

Authors:  R E Morton; J Hankinson; J Nicholson
Journal:  Arch Dis Child       Date:  2004-12       Impact factor: 3.791

2.  Medium-term follow-up of Achilles tendon lengthening in the treatment of ankle equinus in cerebral palsy.

Authors:  Frederick R Dietz; Jay C Albright; Lori Dolan
Journal:  Iowa Orthop J       Date:  2006

Review 3.  Botulinum toxin in children with cerebral palsy.

Authors:  Pratibha Singhi; Munni Ray
Journal:  Indian J Pediatr       Date:  2004-12       Impact factor: 1.967

4.  Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy.

Authors:  T Ubhi; B B Bhakta; H L Ives; V Allgar; S H Roussounis
Journal:  Arch Dis Child       Date:  2000-12       Impact factor: 3.791

5.  Use of rimabotulinum toxin for focal hypertonicity management in children with cerebral palsy with nonresponse to onabotulinum toxin.

Authors:  Joline E Brandenburg; Linda E Krach; Mark E Gormley
Journal:  Am J Phys Med Rehabil       Date:  2013-10       Impact factor: 2.159

6.  Therapeutic use of botulinum toxin in neurorehabilitation.

Authors:  Domenico Intiso
Journal:  J Toxicol       Date:  2011-09-14

7.  Treatment with Botulinum toxin A in a total population of children with cerebral palsy - a retrospective cohort registry study.

Authors:  Maria Franzén; Gunnar Hägglund; Ann Alriksson-Schmidt
Journal:  BMC Musculoskelet Disord       Date:  2017-12-11       Impact factor: 2.362

8.  Protocol for The Toxin Study: Understanding clinical and patient reported response of children and young people with cerebral palsy to intramuscular lower limb Botulinum neurotoxin-A injections, exploring all domains of the ICF. A pragmatic longitudinal observational study using a prospective one-group repeated measures design.

Authors:  Lesley R Katchburian; Kate Oulton; Eleanor Main; Christopher Morris; Lucinda J Carr
Journal:  BMJ Open       Date:  2021-04-21       Impact factor: 2.692

Review 9.  Treating complex movement disorders in children with cerebral palsy.

Authors:  Claire Lundy; Daniel Lumsden; Charlie Fairhurst
Journal:  Ulster Med J       Date:  2009-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.